Teleflex/Arrow corporate warning letter
This article was originally published in The Gray Sheet
Executive Summary
Teleflex subsidiary Arrow International receives corporate warning letter from FDA dated Oct. 10 expressing concerns with Arrow's company-wide quality systems, including procedures for complaint handling, corrective and preventative action, process and design validation, inspection and training. The letter cites three site-specific warning letters issued in 2005 and subsequent inspections performed from June 2005 to February 2007 at Arrow's U.S. facilities, which make catheters and other critical- and cardiac-care devices (1"The Gray Sheet" June 27, 2005, p. 19). FDA had already imposed limitations on Arrow's premarket approvals and certificates to foreign governments based on the prior inspections, and has not imposed any additional sanctions that will have a material financial impact on the company, according to Teleflex. Teleflex, which acquired Arrow on Oct. 1, says it will respond to the letter promptly
You may also be interested in...
Regulatory News In Brief
Biomet warning letter: The firm says it has responded to a recent FDA 1warning letter charging that its Signature personalized patient care system is being marketed without clearance or approval. Biomet believes the system, which is manufactured for Biomet by Materialise NV, is "appropriately marketed" under a 510(k). The company says it explained its reasoning in its unreleased Aug. 3 response letter and is awaiting a formal reply from the agency. FDA posted the July 27 warning letter online last week. The signature employs imaging scans to produce patient-specific tools for use in knee-replacement surgery
Despite Fresh Warning, Arrow Looks To Jumpstart Neonatal Business
Arrow International will return to the neonatal market in November and re-launch the NeoPICC catheter early in 2006, the firm said, commenting on a June 20 warning letter related to an earlier recall
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.